Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B L Tranum

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reports|December 1, 1977
Phase II evaluation of piperazinedione in metastatic breast carcinomaR L Palmer, B A Samal, C B Vaughn, et al.
Cancer Chemotherapy Reports|November 1, 1975
Adriamycin (NSC-123127) plus 5-fluorouracil (NSC-19893): a phase I studyB L Tranum, R L Stephens, D E Lehane, et al.
Cancer|December 15, 1989
Combination chemotherapy and high-dose cyclophosphamide intensification for poor prognosis breast cancer. A Southwest Oncology Group StudyG K Ellis, S Green, S Schulman, et al.
Investigational New Drugs|January 1, 1983
Mitoxantrone in advanced breast cancer: a phase II trial of the Southwest Oncology GroupW A Knight, D D Von Hoff, J A Neidhart, et al.
Cancer Treatment Reports|October 1, 1987
Phase II evaluation of spirogermanium in malignant melanoma: a Southwest Oncology Group StudyJ W Goodwin, K Kopecky, M Slavik, et al.
Cancer Treatment Reports|December 1, 1977
Phase II trial of piperazinedione in Hodgkin's disease, non-Hodgkin's lymphoma, and multiple myeloma: a Southwest Oncology Group studyS E Jones, W G Tucker, A Haut, et al.
Investigational New Drugs|May 1, 1993
Mitoxantrone (dihydroxyanthracenedione) in acute leukemia. An evaluation of two treatment schedules by the Southwest Oncology GroupJ H Saiki, W J Stuckey, J W Athens, et al.
Cancer Treatment Reports|February 1, 1984
Amsacrine (m-AMSA) in squamous cell carcinoma of the uterine cervix: a Southwest Oncology Group studyR D Hilgers, S S Legha, J G Boutselis, et al.
Investigational New Drugs|January 1, 1984
m-AMSA and adenocarcinoma of the endometrium. A Southwest Oncology Group studyR D Hilgers, S S Legha, G A Johnston, et al.
Investigational New Drugs|February 1, 1990
Aclacinomycin A in the treatment of multiple myeloma: a Southwest Oncology Group studyC Karanes, J Crowley, L Sawkar, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reports|December 1, 1977
Phase II evaluation of piperazinedione in metastatic breast carcinomaR L Palmer, B A Samal, C B Vaughn, et al.
Cancer Chemotherapy Reports|November 1, 1975
Adriamycin (NSC-123127) plus 5-fluorouracil (NSC-19893): a phase I studyB L Tranum, R L Stephens, D E Lehane, et al.
Cancer|December 15, 1989
Combination chemotherapy and high-dose cyclophosphamide intensification for poor prognosis breast cancer. A Southwest Oncology Group StudyG K Ellis, S Green, S Schulman, et al.
Investigational New Drugs|January 1, 1983
Mitoxantrone in advanced breast cancer: a phase II trial of the Southwest Oncology GroupW A Knight, D D Von Hoff, J A Neidhart, et al.
Cancer Treatment Reports|October 1, 1987
Phase II evaluation of spirogermanium in malignant melanoma: a Southwest Oncology Group StudyJ W Goodwin, K Kopecky, M Slavik, et al.
Cancer Treatment Reports|December 1, 1977
Phase II trial of piperazinedione in Hodgkin's disease, non-Hodgkin's lymphoma, and multiple myeloma: a Southwest Oncology Group studyS E Jones, W G Tucker, A Haut, et al.
Investigational New Drugs|May 1, 1993
Mitoxantrone (dihydroxyanthracenedione) in acute leukemia. An evaluation of two treatment schedules by the Southwest Oncology GroupJ H Saiki, W J Stuckey, J W Athens, et al.
Cancer Treatment Reports|February 1, 1984
Amsacrine (m-AMSA) in squamous cell carcinoma of the uterine cervix: a Southwest Oncology Group studyR D Hilgers, S S Legha, J G Boutselis, et al.
Investigational New Drugs|January 1, 1984
m-AMSA and adenocarcinoma of the endometrium. A Southwest Oncology Group studyR D Hilgers, S S Legha, G A Johnston, et al.
Investigational New Drugs|February 1, 1990
Aclacinomycin A in the treatment of multiple myeloma: a Southwest Oncology Group studyC Karanes, J Crowley, L Sawkar, et al.
Pageof 3